Medications for Mesenteric Venous Thrombosis
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Mesenteric Venous Thrombosis.
Found 10 Approved Drugs for Mesenteric Venous Thrombosis
Enoxaparin
Brand Names
Lovenox, Enoxiluv
Enoxaparin
Brand Names
Lovenox, Enoxiluv
Form: Injection, Kit
Method of administration: Subcutaneous, Topical, Intravenous
FDA approval date: March 29, 1993
Classification: Low Molecular Weight Heparin
Enoxaparin sodium injection, USP is a low molecular weight heparin [LMWH] indicated for: Prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery, knee replacement surgery, or medical patients with severely restricted mobility during acute illness. For first aid to decrease germs in minor cuts scrapes burns For preparation of the skin prior to injection.
Xarelto
Generic Name
Rivaroxaban
Xarelto
Generic Name
Rivaroxaban
Form: Tablet, Kit, Granule, For
Method of administration: Oral
FDA approval date: July 01, 2011
Classification: Factor Xa Inhibitor
XARELTO is a factor Xa inhibitor indicated: to reduce risk of stroke and systemic embolism in nonvalvular atrial fibrillation.
Ranibizumab
Brand Names
Lucentis, Byooviz, Susvimo, Cimerli
Ranibizumab
Brand Names
Lucentis, Byooviz, Susvimo, Cimerli
Form: Injection
Method of administration: Intravitreal
FDA approval date: June 30, 2006
Classification: Vascular Endothelial Growth Factor Inhibitor
CIMERLI is indicated for the treatment of patients with: CIMERLI, a vascular endothelial growth factor (VEGF) inhibitor, is indicated for the treatment of patients with: Neovascular (Wet) Age-Related Macular Degeneration (AMD).
Apixaban
Brand Names
Eliquis 30-Day, Eliquis
Apixaban
Brand Names
Eliquis 30-Day, Eliquis
Form: Tablet, Kit
Method of administration: Oral
FDA approval date: December 28, 2012
Classification: Factor Xa Inhibitor
Apixaban tablet is a factor Xa inhibitor indicated: to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.
Arixtra
Generic Name
Fondaparinux
Arixtra
Generic Name
Fondaparinux
Form: Injection
Method of administration: Subcutaneous
FDA approval date: July 14, 2011
Classification: Factor Xa Inhibitor
ARIXTRA is a Factor Xa inhibitor (anticoagulant) indicated for: Prophylaxis of deep vein thrombosis (DVT) in adult patients undergoing hip fracture surgery (including extended prophylaxis), hip replacement surgery, knee replacement surgery, or abdominal surgery.
Showing 1-5 of 10
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances